… for the following terms: (nonvalvular or atrial fibrillation or AF or NVAF) AND (warfarin or
Coumadin) and (novel oral anticoagulant or NOAC or dabigatran or Pradaxa) and (real world or …

… dabigatran with warfarin in patients who had atrial fibrillation and who were at risk for stroke.
As compared with warfarin, the 110-mg dose of dabigatran … 150-mg dose of dabigatran was …

… atrial fibrillation who switch from warfarin to dabigatran. Am J Med 2014; 127: 1179-1185. …
with atrial fibrillation who switch from warfarin to dabigatran. Am J Med 2014; 127: 1179-1185. …

… score matching to compare dabigatran with warfarin among patients in two … atrial
fibrillation, dabigatran treatment resulted in improved health outcomes compared with warfarin…

… In a large cohort of carefully matched patients starting dabigatran or warfarin therapy for
atrial fibrillation, we found that dabigatran use was associated with a lower rate of intracranial …

… , a new type of oral anticoagulant that is not vitamin-K dependent, aiming to replace warfarin
… in the warfarin arm of the first international comparison of dabigatran against warfarin in AF …

… uninterrupted dabigatran versus warfarin in patients undergoing ablation of atrial fibrillation.
… paroxysmal or persistent atrial fibrillation to receive either dabigatran (150 mg twice daily) or …

… 2 doses of dabigatran etexilate against warfarin in AF patients … that dabigatran 110 mg bid
was noninferior to warfarin for the … of warfarin and dabigatran etexilate for atrial fibrillation (AF) …

… 2 doses of dabigatran were low and comparable to those on warfarin with or without
transesophageal echocardiography guidance. Dabigatran is a reasonable alternative to warfarin in …

… atrial fibrillation patients with well-controlled blood pressure, the clinical spectrum of intracranial
hemorrhages was similar for patients given warfarin versus dabigatran, … with dabigatran. …